戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 dividuals with emphysema secondary to severe alpha1 antitrypsin deficiency.
2 led trial of A1PI treatment in patients with alpha1 antitrypsin deficiency.
3 ding Gaucher disease, cystic fibrosis and ZZ alpha1-antitrypsin deficiency.
4 that underlies emphysema in individuals with alpha1-antitrypsin deficiency.
5 stemic inflammatory diseases associated with alpha1-antitrypsin deficiency.
6  which underlies misfolding diseases such as alpha1-antitrypsin deficiency.
7 apy for treatment of liver diseases, such as alpha1-antitrypsin deficiency.
8 tions in CF, primary ciliary dyskinesia, and alpha1-antitrypsin deficiency.
9  clinically and cost-effective therapies for alpha1-antitrypsin deficiency.
10 re, early-onset COPD probands without severe alpha1-antitrypsin deficiency.
11  a 34-year-old man with cirrhosis related to alpha1-antitrypsin deficiency.
12 n aggregation-associated diseases, including alpha1-antitrypsin deficiency.
13                     In the classical form of alpha1-antitrypsin deficiency, a misfolded variant alpha
14 ive pulmonary disease (COPD) associated with alpha1-antitrypsin deficiency (AATD).
15 ng, is believed to cause lung destruction in alpha1-antitrypsin deficiency (AATD).
16                               Organoids from alpha1-antitrypsin deficiency and Alagille syndrome pati
17                    The association between Z alpha1-antitrypsin deficiency and juvenile cirrhosis is
18 studies of gene therapy for cystic fibrosis, alpha1-antitrypsin deficiency and lung cancer.
19 ng of genetic and nongenetic modifiers in ZZ alpha1-antitrypsin deficiency and other disorders of pro
20 determine susceptibility to liver disease in alpha1-antitrypsin deficiency and provide evidence that
21  the end-stage liver disease associated with alpha1-antitrypsin deficiency and underscore the contrib
22 nically relevant PiZZ mutation, which causes alpha1-antitrypsin deficiency, and editing of phosphotyr
23 netic disorders, such as cystic fibrosis and alpha1-antitrypsin deficiency, and for other diseases, i
24 with either alcohol-related liver disease or alpha1-antitrypsin deficiency, and only one of the healt
25 he most frequent mutation that causes severe alpha1-antitrypsin deficiency arises in the SERPINA 1 ge
26                                              alpha1-Antitrypsin deficiency (ATD) is a common genetic
27                     In the classical form of alpha1-antitrypsin deficiency (ATD), aberrant intracellu
28 r injury in patients with the classical form alpha1-antitrypsin deficiency (ATD).
29  Less common causes include hemochromatosis, alpha1-antitrypsin deficiency, autoimmune hepatitis, and
30                                       Severe alpha1-antitrypsin deficiency caused by the Z variant (G
31 blished pulmonary mechanics in patients with alpha1-antitrypsin deficiency, chronic obstructive pulmo
32 ess of augmentation therapy (Aug) for severe alpha1-antitrypsin deficiency, comparing strategies of:
33  sensitive measure of disease progression in alpha1 antitrypsin deficiency emphysema than spirometry
34 ents with CF, primary ciliary dyskinesia, or alpha1-antitrypsin deficiency exhibited 3-fold higher mu
35 abolic conditions studied in further detail (alpha1-antitrypsin deficiency, familial hypercholesterol
36 netic hemochromatosis, Wilson's disease, and alpha1-antitrypsin deficiency grow significantly.
37  inhibitor (A1PI) augmentation treatment for alpha1 antitrypsin deficiency has not been substantiated
38 mphysema progression in patients with severe alpha1 antitrypsin deficiency in a randomised controlled
39  insulin signaling in the PiZ mouse model of alpha1-antitrypsin deficiency in which hepatocellular ac
40                                           In alpha1-antitrypsin deficiency, intrahepatocyte accumulat
41                                              Alpha1-antitrypsin deficiency is a genetic disease that
42                                              Alpha1-antitrypsin deficiency is a genetic disorder that
43                                              alpha1-Antitrypsin deficiency is an inherited condition
44                                              alpha1-Antitrypsin deficiency is one of the most common
45  a novel target for development of new human alpha1-antitrypsin deficiency liver disease therapies.
46 tients with alcohol-related liver disease or alpha1-antitrypsin-deficiency liver disease, and only on
47  drug-induced acute liver failure (one), and alpha1-antitrypsin deficiency (one).
48 verity and distribution in 119 subjects with alpha1-antitrypsin deficiency (PiZ phenotype) and groupe
49 ria or tuberculosis, genetic conditions (eg, alpha1-antitrypsin deficiency, primary ciliary dyskinesi
50 y centres in 13 countries if they had severe alpha1 antitrypsin deficiency (serum concentration <11 m
51                                       Severe alpha1-antitrypsin deficiency (typically PiZZ homozygosi
52                           The association of alpha1-antitrypsin deficiency with the development of em